Join the GLP-1 Weight loss adventure, where the personal experiences of Laraine & Christopher Durham meet practical knowledge and the latest GLP1, Mounjaro, Zepbound, and Ozempic updates. From sharing our adventure, tips, and tricks to discussing the latest breakthroughs in weight management medications, our channel is your comprehensive guide to achieving and maintaining a healthier lifestyle. Let's thrive together!
Start your weight loss journey today! We use Mochi Health: joinmochi.com/. Use Laraine’s code for $40 off: QIYGO8.
Disclaimer: The information on the Downsized RU-vid channel is for general informational purposes only and should not be considered medical advice. Always consult a qualified healthcare professional before starting any weight loss medication or treatment.
I just saw the 650 is for new card Starting in Sept that is why is can only be used 5 times. Does not affect our old cards. Hopefully next years card will be better.
I feel a little “safer” since I’m on MJ, but just heard that Barb had her MJ coverage yanked, so you never know, I guess. Also, since they are literally the same meds, supply is supply is supply, right? Once all the vial folks need bigger doses, there goes the pen supply. If compounds become more difficult, now those folks will need brand name/pens. I’ve vowed not to let myself get too anxious about it, tho. And, your level-headed reporting is always helpful in that respect. 😘
Also, I believe that Lilly needs to do better. What a shame that in the U.S. you have to have a certain disposable income to afford needed prescriptions. Shame on EL.
Christopher and Laraine, I'm assuming this svgs card: A, is for new prescriptions only, and B, the new svgs card is for NEW prescriptions I don't think they'd take back the svgs card that we're already using. I really think w.5 months left in the year, that this new svgs card applies to Sept - Dec (5mos) for new scripts.
CD: its hard to say - if there is a effective date in the terms and conditions I do not see it. Just and expiration date. If you have an existing coupon it should work, Laraine just filled one today at the $550 price
CD: heres the link to the page - it doesn't appear to specifically say. But I have never looked at this one before. mounjaro.lilly.com/savings-resources?CjwKCAjw8rW2BhAgEiwAoRO5rJwCvdD0_YZ9arBEjUf2hj2Va3jurkBzW0pwXwufOIXpCw9n9buSjhoCneoQAvD_BwE&campaign=20975809605&adgroup=158741897936&ad=691320615981&CjwKCAjw8rW2BhAgEiwAoRO5rJwCvdD0_YZ9arBEjUf2hj2Va3jurkBzW0pwXwufOIXpCw9n9buSjhoCneoQAvD_BwE&gad_source=1&gclid=CjwKCAjw8rW2BhAgEiwAoRO5rJwCvdD0_YZ9arBEjUf2hj2Va3jurkBzW0pwXwufOIXpCw9n9buSjhoCneoQAvD_BwE#savings
It's sad you guys have to go through all this nonsense. I've been on the 2.5 compounded tirzepatide for just over 3 months now, losing weight every week, (35 lbs so far, 65 to go). And my doc's office administers the shots for $75 a week, (not covered by the big 3-letter insurance company).
Saw David Ricks on GMA this morning. Everything he said sounded so disingenuous. If I weren’t aware of the REAL situation (as I am as an insider), I probably would have bought it and thought Lilly was such a great company that cares for those who need these meds. 🙄
Without Eli Lilly, nobody would have these drugs and the profits that come from them might fund the next cancer cure for a child - that’s how it works. I don’t want the old-fashioned way of losing weight, but it’s still available to me.
They'll never release the bigger dose vials. They know people will just get 15mg doses and split them into 2, 3 or 6 doses. This is EL's cash cow. They'll never give up their revenues. They do it in other countries because it's not a crazy price overseas so less incentive for people to split doses.
I just picked mine up also it went up 30.07 more than last month. I was so excited to get the pen but I’ll probably be going back to compound. I can’t tell the difference either but I can change my injection sites more with the pen.
Omg I HATE PICKING UP THESE MEDS!!! There’s a problem every. single. time. I just got home from my 2nd Walgreens trip of the day with meds in hand. Hooray!🎉 and I was charged the $550- not the new price of $650. So that was good. I also realized it had only been 22 days between fills. So maybe that was the problem? 🤷♀️ The Dr had sent it in, and they had it / filled it early.
As usual, great update. Really appreciate the information and your insight. Good, objective insight and observations! I just watched another channel's take and it seemed like he was a Eli Lilly salesperson. :-) You are spot on, this is self-serving for Lilly. Their market share is adversely impacted by the shortage and the ability of 503A pharmacies to provide compounded versions. This is an integrated strategy that relates to the (a) declaration by Lilly that Zepbound is no longer in shortage, and (b) the cease and desist letters sent out by counsel a few weeks ago. Here's my take - the vials will take the injector pen pressure off the higher doses - allowing those pieces of hardware to be shifted to dosages above 5 mg - hence helping the case that those are "commercially available." Then, because the 2.5 and 5 will be available in vials (presumably in higher quantities) and available directly form Lilly, the availability issue is further mitigated on those doses. All will be "commercially available" and then, poof, there goes the justification to compound. Now there's pricing - they needed to come in at a level that was close to compounded tirzepititide - it is around 2x higher, yes, but it is at a level that if they shut down compounding, it is more likely folks will go with Zepbound than shift to compounded semaglutide. (think protection of market share). It is an integrated legal and marketing strategy designed to dismantle compounding pharmacies as competitor and secure the new users via a more affordable on-ramp to Zepbound. Don't like the potential impact on those who use compounds but I get it. Lilly wants to realize more profit from Zepbound and this is a way to do it. This certainly isn't a charitable act to help users. Don't expect to see vials in higher doses because there is more risk of consumers going to higher dosages that could cause physical problems. The key to all of this is for Lilly is to be able to say that all dosage levels are commercially available (appearing on a shortage list is an FDA - created animal - they are setting in place legal arguments to fight with FDA and to set up claims against the compounding pharmacies). They obviously thought long and hard about this. Will be fascinating to see this play out over the rest of the year. Don't expect FDA to take a firm position before the election - yes, politics does play a role in this too. 🙂
Long term the compounders are just an annoyance. Lilly is plotting to own the 120 million obese people in the US and many more globally. They want the entire much larger pie. Before competitors can take share Lilly wants
But they also raised the coupon price for those with insurance but it's not covered. It went from $550 to $650 and now you can only use it for 5 fills per year instead of 13. Bottom line, they're showing just how greedy they are. Rope in a bunch of new patients with lower cost starting dose vials and then you get screwed worse than before when you need higher doses. Essentially our annual cost doubles! This is pure greed disguised to look like they're being charitable. Money grab!
@@thedownsized that’s not 100% correct. When the drug becomes available compounding should stop by law. Now if you have some kind of allergy and need a different ingredient that’s a different story. A reputable provider wouldn’t say you have an allergy you didn’t have in the past. Would be odd to the FDA all your past patients have an allergy they didn’t have in the past. Also an overloaded of b vitamins are not good for you.
@@jenf836 CD: I suspect the language and the interpretation of the FDA's guidance would end up in court. I am certainly not a lawyer but it does appear compounders could continue to operate to some level under 503A. It appears there is a case for both the compounding side and the Patent holder side. So it sounds like a court battle to me! Conditions of Section 503A Under section 503A of the FD&C Act, a compounded drug product is exempt from sections 501(a)(2)(B), 502(f)(1), and 505 of the FD&C Act if it meets the conditions of section 503A of the FD&C Act. Specifically, the compounded drug product qualifies for the exemptions if: 1. The drug product is compounded for an identified individual patient based on the receipt of a valid prescription order, or a notation, approved by the prescribing practitioner, on the prescription order that a compounded product is necessary for the identified patient (section 503A(a) of the FD&C Act). Here is the link thot he FDA's guidance chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/www.fda.gov/media/94393/download#:~:text=Section%20503A%20describes%20the%20conditions,f)(1)%20(concerning%20the
The new patients starting the vials need to seriously think about what they will do when they need to dose up beyond 5mg if they are self pay…and the coupon (only good for the insured) for the pens will now only be good for five months….so many of these people will start and then have to stop or switch to a compound if that’s still available I guess.
Well said Christopher. Still priced too high, and these vials are Waaay more than other countries. And, to your point, what about 7.5, 10 etc.? If 5mg is at the svgs card price, will 7.5 and 10/12.5/15 be incrementally higher...guaranteed they will be. Very interesting...
I mean they are paying attention which is great , but still haven’t been able to convince their shareholders that prices need to come down to everyday levels for the average person. Large cost for a few individuals and insurance companies who cover or lower cost for a larger pool of the market share. They are shooting themselves in the foot if they keep prices where they are. Most insurance companies do not cover and the average person cannot afford out of pocket costs. If they don’t do something they know it will be a lose lose situation. What good is your drug if no one buys?
Agreed. They have to know that they care creating bad blood with consumers who will (as SOON as their competitors release alternative glp1"s) jump ship for many reasons including not liking Lilly's apparent? culture of no empathy for consumers.
I'd bet 20 quid that Lilly is increasing their net profit per dose substantially by cutting out the middlemen and going direct- even with the 'price drop'. Next up is the UK NICE final approvals for Lillys Mounjaro to be licensed for NHS use for obesity management in UK- reports be released in mere weeks and will create a tidal wave of users here in the UK.
These Lilly business strategies and moves are fascinating- would love to be a fly on the wall as they sit around the table figuring out next steps! They are going to get a tidal wave of new users for Q1 24 and the entirety of 25, scooping up all possible sales before the competition hits the market in 26......
Also remember that alongside this, Eli Lilly changes the discount for their savings card. Those who didn't have coverage via commercial insurance have been paying $550 and now will need to pay $650. Prices with the savings card on LillyDirect still seem to be $550 though.
While it’s a start for Eli Lilly I have my doubts. I am using a compound and I am almost at my goal. However, I feel it will be a lifelong medication in order for me to maintain my loss while using a lower maintenance dose. I feel them starting at the lower milligram vials is there way to get new customers “ hooked” so to speak knowing they will be lifelong customers. Plus with the lower doses they can attract way more people who have just started their journey. Thanks for your information always appreciated.
I partially like the direction of this move. I don’t however, like the wastefulness of single-dose vials. Also, all vial prices and dosages should be capped at the discount card price. The price increment between 2.5 and 5 is too large. All dosages should be available in a monthly vial and capped at the discount card price or better.
The demonstration was so helpful. I haven’t confirmed it, but I believe they raised the price with the savings card to $650 instead of $550. Like you, I’ve got school tuition payments to worry about, and I’ve been looking to cut corners anywhere I can. At this point, this medicine is a need for me and my husband because we’re having such great success, but $1300 a month is a lot!
The demonstration was so helpful. I haven’t confirmed it, but I believe they raised the price with the savings card to $650 instead of $550. I just put my son in a special needs school, and I’ve been looking to cut corners anywhere I can. At this point, this medicine is a need for me and my husband because we’re having such great success, but $1300 a month is a lot!
Exciting times! We are on the forefront of a paradigm change. Going back to Uni in a month to learn the science behind these innovative treatments, also developing adjunct food, wellness and beauty products as we speak. Thanks for the updates as always!
@@thedownsized I’m sorry. I am not a doctor, I just thought logically…. There is probably a ‘pressure of the medicine injected’ reason or something as why they don’t make them. I’ll try to look it up. Also, your provider(doctor) may know more or know of a different medical website to order supplies. Sorry again if I got your hopes up. Thank you for your videos!
As far as the suicidal thoughts…how do we know that wasn’t a pre-existing problem or would have happen anyway? Also, everyone I know is taking the compound…so I don’t think we are taking anyone’s drugs. Plus, I think it’s disingenuous of these people who are “taking up” for the diabetes patients. These were the same people who spent their time shaming them about using medications in the first place because they should just eat keto and do intermittent fasting. Now all of a sudden, they are mad that the diabetic patients can’t get their much needed medications. 🤔
